The Treating Fairly Research Award supports research addressing hematologic diseases and disorders disproportionately impacting specific communities. It provides $200,000 to ASH members with advanced degrees conducting equitable hematology research in the U.S., Mexico, or Canada, aiming to advance fair patient outcomes.
Eligible applicants are ASH members with a PhD, MD/DO, or MD/DO, PhD who are no longer eligible for certain ASH awards. They must be Principal Investigators at eligible institutions in the U.S., Mexico, or Canada, hold citizenship or visa/PR status, and have limited other funding.
